Cleave Therapeutics

Developer of enzyme inhibitors designed to target and treat neurodegenerative and oncological pathways used by cancer cells to grow. The company develops novel, small-molecule therapeutic inhibitors drugs that affect protein-degradation pathways upon which cancer cells depend for survival, enabling healthcare organizations to help patients get cured of cancer.

New Enterprise Associates

🏥 Healthcare